These vascular amyloid deposits have also been associated with accumulation of many inflammatory mediators [194], including CLU (clusterin; Apo J), a potent complement regulator found at significantly higher levels in CAA patients than in those with AD or healthy controls, based on laser-captured cortical tissue proteome analysis [194]. Here, CLU is linked to Alzheimer disease.